Grandeur Peak Global Advisors’s Aratana Therapeutics, Inc. PETX Stock Holding History

Grandeur Peak Global Advisors’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,090,868	Closed	-$3.93M	–	93
2019 Q1	$3.93M	Buy	1,090,868 +269,830	+33%	+$1.17M	0.45%	48
2018 Q4	$5.03M	Sell	821,038 -32,850	-4%	-$200K	0.65%	42
2018 Q3	$4.99M	Buy	853,888 +141,750	+20%	+$708K	0.52%	56
2018 Q2	$3.03M	Buy	712,138 +161,675	+29%	+$815K	0.31%	62
2018 Q1	$2.43M	Buy	550,463 +12,100	+2%	+$54K	0.27%	67
2017 Q4	$2.83M	Hold	538,363	–	–	0.37%	57
2017 Q3	$3.3M	Hold	538,363	–	–	0.5%	50
2017 Q2	$3.89M	Buy	538,363 +155,000	+40%	+$953K	0.56%	54
2017 Q1	$2.03M	Buy	383,363 +27,225	+8%	+$184K	0.33%	60
2016 Q4	$2.56M	Sell	356,138 -38,312	-10%	-$310K	0.47%	53
2016 Q3	$3.69M	Sell	394,450 -197,900	-33%	-$1.64M	0.72%	47
2016 Q2	$3.74M	Sell	592,350 -28,500	-5%	-$183K	0.81%	44
2016 Q1	$3.43M	Buy	620,850 +160,175	+35%	+$602K	0.69%	49
2015 Q4	$2.57M	Buy	460,675 +440,225	+2,153%	+$2.91M	0.53%	64
2015 Q3	$173K	Sell	20,450 -45,650	-69%	-$773K	0.04%	107
2015 Q2	$999K	Hold	66,100	–	–	0.2%	85
2015 Q1	$1.06M	Sell	66,100 -113,575	-63%	-$2.02M	0.22%	79
2014 Q4	$3.2M	Sell	179,675 -43,050	-19%	-$536K	0.72%	52
2014 Q3	$2.24M	Buy	222,725 +42,825	+24%	+$519K	0.54%	64
2014 Q2	$2.81M	Buy	179,900 +49,800	+38%	+$706K	0.61%	59
2014 Q1	$2.42M	Buy	+130,100	New	+$2.61M	0.57%	65

Other funds holding PETX

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

WIC

Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OAC

OMERS Administration Corp Toronto, Ontario, Canada $16.7B AUM 35.96% 1-Year Est. Return

Grandeur Peak Global Advisors's PETX Position: Q2 2019 in Review

Grandeur Peak Global Advisors sold out of Aratana Therapeutics, Inc. (PETX) in Q2 2019, closing a stake of 1,090,868 shares — an estimated $3.93M sold.

Grandeur Peak Global Advisors first reported a position in PETX in Q1 2014 and held it in 21 quarters. The position peaked at $5.03M in Q4 2018. 103 funds tracked by Wall St. Rank hold PETX as of Q2 2019.

Grandeur Peak Global Advisors reported no remaining Aratana Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
Grandeur Peak Global Advisors sold 1,090,868 Aratana Therapeutics, Inc. shares in Q2 2019, an estimated $3.93M.
Grandeur Peak Global Advisors first reported a position in Aratana Therapeutics, Inc. in Q1 2014 and held it in 21 quarters.
Grandeur Peak Global Advisors's Aratana Therapeutics, Inc. position peaked at $5.03M in Q4 2018.
103 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q2 2019.

Based on Grandeur Peak Global Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.